# Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

> **NCT01726439** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 3434 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01726439
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 3434 (ACTUAL)
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01726439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01726439, "Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01726439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*